Clinical trials
Recruiting Breast Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| Eli Lilly and Company | 1 |
| Ensem Therapeutics | 1 |
| FangYi | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Fujian Cancer Hospital | 1 |
| Haiyan Li | 1 |
| Maastricht University Medical Center | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Diseases | 16 |
| Breast Neoplasms | 12 |
| Neoplasms | 4 |
| Neoplasms by Site | 4 |
| Endometrial Neoplasms | 2 |
| Head and Neck Neoplasms | 2 |
| Hereditary Sensory and Autonomic Neuropathies | 2 |
| Neoplasm Metastasis | 2 |
| Ovarian Neoplasms | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
Trials
Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.